Zhi-Bo Zhang - Fujian Provincial Institute of Abdominal Surgery, Fujian Medical University

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 35 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term Surgical Outcomes of Bile Duct Tumor Thrombus Versus Portal Vein Tumor Thrombus for Hepatocellular Carcinoma: a Propensity Score Matching Analysis

Yi-Nan Li,Shao-Ming Wei,Yang-Kai Fu,Zhen-Xin Zeng,Li-Ming Huang,Jia-Hui Lv,Wei-Zhao Chen,Yong-Gang Wei,Zhi-Bo Zhang,Jian-Yin Zhou,Jia-Yi Wu,Mao-Lin Yan

Frontiers in Oncology (2024)

引用0浏览0WOS引用

Perioperative Lenvatinib Combined with Tislelizumab Plus Transcatheter Arterial Chemoembolization in Resectable Hepatocellular Carcinoma with High-Risk of Recurrence: A Prospective, Single-Arm, Phase 2 Trial

Jia-Yi Wu,Yang-Kai Fu,Tianfu Wen,Shuang-Jia Wang, Jiafei Chen,Zhibo Zhang, Chongyuan Liu,Wei Wang,Lu Fang, Zhong Tang,Yufeng Chen,Maolin Yan

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用0浏览0引用

Transcatheter Arterial Chemoembolisation Combined with Lenvatinib Plus Camrelizumab As Conversion Therapy for Unresectable Hepatocellular Carcinoma: a Single-Arm, Multicentre, Prospective Study

Xu-Kun Wu,Lan-Fang Yang,Yu-Feng Chen,Zhong-Wu Chen, Hao Lu, Xue-Yi Shen,Min-Hui Chi,Liang Wang,Hui Zhang, Jia-Fei Chen,Jing-Yao Huang,Yong-Yi Zeng,Mao-Lin Yan,Zhi-Bo Zhang

ECLINICALMEDICINE (2024)

引用0浏览0WOS引用

Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion Surgery

Zhen-Xin Zeng,Jia-Yi Wu,Jun-Yi Wu,Zhi-Bo Zhang,Kai Wang,Shao-Wu Zhuang,Bin Li,Jian-Yin Zhou,Zhong-Tai Lin,Shu-Qun Li,Yi-Nan Li,Yang-Kai Fu,Mao-Lin Yan

LIVER CANCERno. 5 (2024): 498-508

引用0浏览0WOS引用

Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study

Xiangye Ou,Junyi Wu,Jiayi Wu,Yangkai Fu,Zhenxin Zeng,Shuqun Li,Yinan Li,Deyi Liu,Han Li,Bin Li,Jianyin Zhou,Shaowu Zhuang,Shuqun Cheng,Zhibo Zhang,Kai Wang,Shuang Qu,Maolin Yan

CANCER RESEARCH AND TREATMENTno. 4 (2024): 1207-1218

引用0浏览0WOS引用

Serum Alpha-Fetoprotein Response As a Preoperative Prognostic Indicator in Unresectable Hepatocellular Carcinoma with Salvage Hepatectomy Following Conversion Therapy: a Multicenter Retrospective Study

Kong-Ying Lin,Jian-Xi Zhang,Zhi-Wen Lin,Qing-Jing Chen,Liu-Ping Luo,Jin-Hong Chen,Kui Wang,Sheng Tai,Zhi-Bo Zhang, Shi-Feng Wang,Jing-Dong Li,Kai Wang,Lu Zheng,Si-Ming Zheng, Meng-Meng Wu,Ke-Can Lin,Tian Yang,Yong-Yi Zeng

Frontiers in Immunology（2024）

引用0浏览0WOS引用

HNRNPL Facilitates Ferroptosis in Hepatocellular Carcinoma Cells by Promoting S100A9 Expression

Lanfang Yang,Zhibo Zhang,Xiangqing Yao,Xukun Wu, Zhao Zhang

TRANSLATIONAL ONCOLOGY (2024)

引用0浏览0WOS引用

Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma after Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study

Jun-Yi Wu,Jia-Yi Wu,Yang-Kai Fu,Xiang-Ye Ou,Shu-Qun Li,Zhi-Bo Zhang,Jian-Yin Zhou,Bin Li,Shuang-Jia Wang,Yu-Feng Chen,Mao-Lin Yan

Annals of Surgical Oncologyno. 5 (2024): 3073-3083

引用0浏览0WOS引用

The TAE Score Predicts Prognosis of Unresectable HCC Patients Treated with TACE Plus Lenvatinib with PD-1 Inhibitors

Zhen-Xin Zeng,Jia-Yi Wu,Jun-Yi Wu,Yi-Nan Li,Yang-Kai Fu,Zhi-Bo Zhang,De-Yi Liu,Han Li,Xiang-Ye Ou,Shao-Wu Zhuang,Mao-Lin Yan

HEPATOLOGY INTERNATIONALno. 2 (2024): 651-660

引用0浏览0WOS引用

Clinical Complete Response after Conversion Therapy for Unresectable Hepatocellular Carcinoma: is Salvage Hepatectomy Necessary

Jia-Yi Wu,Jun-Yi Wu,De-Yi Liu,Han Li,Shao-Wu Zhuang,Bin Li,Jian-Yin Zhou,Jing-Yao Huang,Zhi-Bo Zhang,Shu-Qun Li,Mao-Lin Yan,Yao-Dong Wang

JOURNAL OF HEPATOCELLULAR CARCINOMA (2023): 2161-2171

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn